Paronychia

Entity type image
Type: Keyphrase
Name: Paronychia
First reported May 18 2013 - Updated May 18 2013 - 1 reports
erlotinib
erlotinib

Dermatologic Adverse Events Associated With Targeted Therapies

Novel cancer therapies have brought about unprecedented improvements in survival along with decreased hematopoietic toxicities, when compared with cytotoxic chemotherapy. Therefore, other components of the cancer experience have come forward, such as ... [Published Cancernetwork.com - May 18 2013]

Quotes

PRIME ( "203) Study Design The PRIME (Panitumumab Randomized trial In combination with chemotherapy for Metastatic colorectal cancer to determine Efficacy) (" 203) trial is a global, multicenter, randomized Phase 3 study designed to evaluate (primary endpoint of PFS) Vectibix (6...
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metasta ... [Published Individual.com - May 15 2013]

More Content

All (4) | News (4) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Dermatologic Adverse Events Associated With Tar... [Published Cancernetwork.com - May 18 2013]
New Analyses Identify Predictive Biomarkers For... [Published Individual.com - May 15 2013]
Amgen Announces Top-Line Results of Vectibix® (... [Published PipelineReview - May 08 2013]
Amgen announces top-line results of Vectibix® (... [Published European Pharmaceutical Review - May 08 2013]
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.